Tag: off-label
Improving global access to an effective MS treatment
New recommendations support use of rituximab to treat MS in low-resource settings
Relevant publications
Publications from MSIF and other stakeholders in support of work on access to MS healthcare.
Off-label treatments for MS
MSIF's work relating to off-label DMTs for MS
Improving access to MS treatment and healthcare
Addressing barriers to accessing treatment at a global, regional and national level